secwatch / observer
8-K filed October 15, 2024, 7:59 PM ET ticker ARAY CIK 0001138723
leadership confidence high sentiment neutral materiality 0.40

Accuray CEO Suzanne Winter returns from medical leave; Chalke resumes CCO role

ACCURAY INC

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Sandeep Chalke

Senior Vice President, Chief Commercial Officer
ARAY · ACCURAY INC
Effective
2024-10-15
Filed
October 15, 2024, 7:59 PM ET
Sandeep Chalke, who served as the Company’s interim Chief Executive Officer, will continue to serve as the Company’s Senior Vice President, Chief Commercial Officer.
Role change

Suzanne Winter

Chief Executive Officer and President
ARAY · ACCURAY INC
Effective
2024-10-15
Filed
October 15, 2024, 7:59 PM ET
On October 15, 2024, Accuray Incorporated (the “Company”) announced that Suzanne Winter, the Company’s Chief Executive Officer and President, has returned from her medical leave of absence and reassumed her duties as the Company’s Chief Executive Officer and President, effective the same date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sandeep Chalke changed role as Senior Vice President, Chief Commercial Officer at ACCURAY INC.

Action
returned from interim CEO role to permanent role
Role
Senior Vice President, Chief Commercial Officer
Exact text from the filing
Sandeep Chalke, who served as the Company’s interim Chief Executive Officer, will continue to serve as the Company’s Senior Vice President, Chief Commercial Officer.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Suzanne Winter changed role as Chief Executive Officer and President at ACCURAY INC.

Action
returned from medical leave and reassumed duties
Role
Chief Executive Officer and President
Exact text from the filing
On October 15, 2024, Accuray Incorporated (the “Company”) announced that Suzanne Winter, the Company’s Chief Executive Officer and President, has returned from her medical leave of absence and reassumed her duties as the Company’s Chief Executive Officer and President, effective the same date.
View on SEC.gov

ACCURAY INC filing history →

Source: SEC EDGAR
accession 0000950170-24-114477
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.